Background and Objectives. Hereditary hemochromatosis (HHC) is a common, re
cessively inherited, genetic disorder associated with an abnormality of th
HFE gene. Subjects homozygous for a point mutation in the gene coding seque
nce, leading to the amino acid substitution C282Y, are usually by the disea
se. A second point mutation, causing the amino acid substitution H63D, has
been described, and compound heterozygotes for the two or homozygotes for t
he H63D mutation at risk of developing a milder form of HHC. In populations
of northern European origin the C282Y substitution accounts for more than
90% of cases of HHC. In Italy, however, fewer than 70% of patients with HHC
are homozygous or compound heterozygous for HFE mutations. Even in the abs
ence of mutations in its coding region, the HFE gene might be involved in t
he pathogenesis of HHC through inhibition of transcription of the gene or r
educed stability of its mRNA.
Design and Methods. Since little is known about the regulation of HFE expre
ssion, we investigated 17 subjects heterozygous for one of the HFE mutation
s and with biochemical evidence of iron overload and compared the levels of
wild type and mutated mRNAs in their peripheral blood cells. c-DNA regions
flanking the mutated codons were amplified by reverse transcriptase polyme
rase chain reaction (PCR). PCR products derived from the two alleles were d
ifferentiated and quantified by digestion with restriction enzymes, electro
phoresis in an agarose stained with ethidium bromide and densitometric scan
ning of the gel.
Results. In all cases wild type and mutated mRNAs were expressed at similar
levels, suggesting that reduced expression of an HFE allele coding a norma
l protein is not involved in the pathogenesis of iron overload. However, we
can not rule out that a tissue specific regulation of HFE expression in th
e cells involved in iron absorption is altered and contributes to the patho
genesis of the disease.
Interpretation and Conclusions. Our results suggest that primary iron overl
oad is a multigenic syndrome; this hypothesis is strongly supported by the
recent demonstration that the juvenile hemochromatosis locus maps to human
chromosome Iq. (C) 2000, Ferrata Storti Foundation.